Levocabastine HCl ophthalmic suspension 0.05% | |
---|---|
Trade Name | |
Orphan Indication | Vernal keratoconjunctivitis |
USA Market Approval | USA |
USA Designation Date | 1988-02-29 00:00:00 |
Sponsor | Iolab Pharmaceuticals;500 Iolab Drive;Claremont, California, 94608 |